Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group.

Circ Cardiovasc Genet

Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Epidemiology Branch, 6701 Rockledge Drive/ MSC 7935, Bethesda, MD20892, USA.

Published: December 2010

In January 2009, the National Heart, Lung, and Blood Institute convened a 28-member multidisciplinary Working Group to update the recommendations of a 2004 National Heart, Lung, and Blood Institute Working Group focused on Guidelines to the Return of Genetic Research Results. Changes in the genetic and societal landscape over the intervening 5 years raise multiple questions and challenges. The group noted the complex issues arising from the fact that technological and bioinformatic progress has made it possible to obtain considerable information on individuals that would not have been possible a decade ago. Although unable to reach consensus on a number of issues, the working group produced 5 recommendations. The working group offers 2 recommendations addressing the criteria necessary to determine when genetic results should and may be returned to study participants, respectively. In addition, it suggests that a time limit be established to limit the duration of obligation of investigators to return genetic research results. The group recommends the creation of a central body, or bodies, to provide guidance on when genetic research results are associated with sufficient risk and have established clinical utility to justify their return to study participants. The final recommendation urges investigators to engage the broader community when dealing with identifiable communities to advise them on the return of aggregate and individual research results. Creation of an entity charged to provide guidance to institutional review boards, investigators, research institutions, and research sponsors would provide rigorous review of available data, promote standardization of study policies regarding return of genetic research results, and enable investigators and study participants to clarify and share expectations for the handling of this increasingly valuable information with appropriate respect for the rights and needs of participants.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090664PMC
http://dx.doi.org/10.1161/CIRCGENETICS.110.958827DOI Listing

Publication Analysis

Top Keywords

working group
20
study participants
16
national heart
12
heart lung
12
lung blood
12
blood institute
12
return genetic
12
institute working
8
provide guidance
8
genetic
7

Similar Publications

Article Synopsis
  • Around 90% of varicella (chickenpox) infections are mild, but adults can experience more severe cases, prompting a study in Florence, Italy, to assess immunity levels post-vaccination.
  • A survey of 430 adults (ages 18-94) showed that 89.5% tested positive for varicella antibodies, with no significant differences based on sex or nationality.
  • The findings indicated that while vaccination efforts have improved immunity, there is still a notable susceptibility (11.6%) among women aged 18-49, emphasizing the need for ongoing vaccination campaigns and awareness.
View Article and Find Full Text PDF

Outcome of primary hemophagocytic lymphohistiocytosis: a report on 143 patients from the Italian Registry.

Haematologica

August 2024

Antonino Trizzino, Simona Gobbi, Fraia Melchionda, Marco Zecca, Elena Mastrodicasa, Massimo Provenzi, Monica Cellini, Daniela Onofrillo, Marco Rabusin, Bernd Raffeiner, Rosamaria Mura, Vito Miraglia, Alessandra Tozzo.

Primary hemophagocytic lymphohistiocytosis (pHLH) is a severe, life-threatening hyperinflammatory syndrome caused by defects in genes of the granule-dependent cytotoxic pathway. Here we investigated the clinical presentation and outcome in a large cohort of 143 patients with pHLH diagnosed in the last 15 years and enrolled in the Italian registry. The median age at diagnosis was 12 months (interquartile range, 2-81), and 92 patients (64%) fulfilled the HLH-2004 criteria.

View Article and Find Full Text PDF
Article Synopsis
  • Major serotypes of Shiga toxin-producing E. coli (STEC) usually have a specific genetic region called the locus of enterocyte effacement (LEE) which helps them cause infections by forming lesions on intestinal cells.* -
  • There is limited information on STEC that lack this LEE, even though they can still be very harmful.* -
  • This study reports the complete genomes of eight LEE-negative STEC isolates found in patients with hemolytic-uremic syndrome, contributing valuable data to the understanding of these bacteria.*
View Article and Find Full Text PDF

A European code of good practice for hyperbaric oxygen therapy - Review 2022.

Diving Hyperb Med

December 2023

Prepared by the Working Group «SAFETY» of the COST Action B14 «HYPERBARIC OXYGEN THERAPY» May 2004 - Update 2022.

View Article and Find Full Text PDF

We studied the risk factors, etiology, clinical manifestations, and treatment outcomes of COVID-19-associated invasive candidiasis (COVID-IC) in adult patients admitted to six medical facilities in St. Petersburg. (November 2020-December 2022).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!